• CHI3L1-IN-5: Workflow-Driven Advances in Neuroinflammation R

  2026-05-25

  CHI3L1-IN-5 (Compound Z17) offers unique dual-action modulation—selective NF-κB pathway inhibition and restoration of astrocyte amyloid-beta clearance—in experimental models of neurodegeneration. This guide delivers actionable workflows, troubleshooting insights, and protocol parameters to accelerate translational Alzheimer's disease research.

• Nanozyme-Driven Clearance of Intracellular Bacteria in CRC I

  2026-05-24

  The reference study introduces a self-activatable polymeric nanozyme strategy that precisely eradicates Fusobacterium nucleatum within tumor-associated macrophages, thereby reversing immunosuppression and enhancing anti-CD47 immunotherapy in colorectal cancer models. These findings highlight the importance of targeting intramacrophage bacterial reservoirs to potentiate immunotherapeutic efficacy.

• Biotin-tyramide: Elevating Enzyme-Mediated Signal Amplificat

  2026-05-23

  Biotin-tyramide enables ultrasensitive, HRP-catalyzed signal amplification in IHC, ISH, and aptamer-based biosensors. Leveraging recent breakthroughs in structure-switching aptamer assays, this reagent unlocks superior sensitivity and spatial resolution for research imaging and detection workflows.

• HR-LCMS/MS Identifies Astragalus dasyanthus as a Glabrol Pro

  2026-05-22

  This study presents a streamlined HR-LCMS/MS workflow for rapid dereplication of plant-derived autophagy inducers, culminating in the novel identification of Astragalus dasyanthus as a new natural source of glabrol. The method enables high-throughput screening of complex extracts for autophagy-modulating compounds, advancing the search for agents relevant to neurodegeneration and metabolic regulation.

• Jasplakinolide: Precision Actin Polymerization for Translati

  2026-05-22

  Explore how Jasplakinolide, a gold-standard actin polymerization inducer, empowers translational researchers to decode cytoskeletal dynamics and bridge chemical genetics with disease modeling. This thought-leadership piece integrates validated protocols, mechanistic insight, and competitive benchmarking, highlighting APExBIO’s Jasplakinolide (SKU B7189) as a cornerstone for robust cell biology and antifungal discovery.

• Refining In Vitro Drug Response Metrics in Cancer Research

  2026-05-21

  Schwartz's dissertation advances in vitro analysis of anticancer drug efficacy by separating proliferative arrest from cell death, revealing that most drugs induce both effects in distinct proportions and timelines. These findings highlight the need for nuanced measurements beyond traditional viability assays, with direct implications for translational cancer research and preclinical model design.

• Nitrocefin: Chromogenic Cephalosporin Substrate for β-Lactam

  2026-05-21

  Nitrocefin empowers researchers with precise, rapid colorimetric detection of β-lactamase activity, facilitating antibiotic resistance profiling and inhibitor screening in both clinical and experimental workflows. This guide distills best practices, advanced troubleshooting, and recent innovations—ensuring optimal assay performance and translational impact.

• ML-7 Hydrochloride: Selective Myosin Light Chain Kinase Inhi

  2026-05-20

  ML-7 hydrochloride is a potent and selective myosin light chain kinase inhibitor used to modulate muscle contraction and cellular motility. Its utility in cardiovascular and vascular dysfunction models is supported by robust, quantitative evidence. APExBIO supplies validated, research-grade ML-7 hydrochloride (A3626) optimized for bench reproducibility.

• Dynamic Expansion of Atrial Slow Conduction in Persistent AF

  2026-05-20

  Lange et al. provide robust evidence that, in an animal model of persistent atrial fibrillation (AF), regions of slow conduction in the atria dynamically expand in response to premature electrical stimulation. This work advances mechanistic understanding of conduction abnormalities in AF, with implications for targeting arrhythmogenic substrate in future interventions.

• Jasplakinolide: Advanced Actin Polymerization Inducer in Res

  2026-05-19

  Jasplakinolide, a potent actin polymerization inducer from APExBIO, enables precision manipulation of cytoskeletal dynamics in cell biology and antifungal studies. This article delivers actionable workflows, troubleshooting strategies, and data-driven insights to help researchers unlock the full potential of this membrane-permeable actin modulator.

• AM251 and the CB1 Receptor: Precision Tools for Translationa

  2026-05-19

  This article explores the mechanistic and translational landscape of AM251—a potent CB1 receptor antagonist—highlighting its role in dissecting endocannabinoid signaling in pain, neuroimmune, and metabolic research. Integrating mechanistic insights, protocol guidance, and competitive positioning, it guides researchers in leveraging AM251 for advanced cannabinoid receptor research, bridging preclinical findings and future clinical impact.

• Triazole ALDH2 Activators: Advancing Therapy for Myocardial

  2026-05-18

  The referenced study reports the discovery and evaluation of novel triazole-based aldehyde dehydrogenase 2 (ALDH2) activators, with compound Z17 showing unprecedented activation potency and improved water solubility. These findings advance the preclinical development of ALDH2 activators as a therapeutic strategy for myocardial ischemia-reperfusion injury, addressing unmet clinical needs.

• Modeling Stroma-Mediated Chemoresistance in PDAC with 3D Org

  2026-05-18

  Schuth et al. present a patient-specific 3D co-culture system integrating pancreatic ductal adenocarcinoma (PDAC) organoids with matched cancer-associated fibroblasts (CAFs) to dissect stroma-driven chemoresistance. Their work reveals key molecular interactions—especially epithelial-to-mesenchymal transition (EMT) signaling—shaping tumor response to chemotherapy and provides a data-rich framework for future drug screening and microenvironment research.

• Applied Use of (-)-Blebbistatin in Cytoskeletal Dynamics Res

  2026-05-17

  (-)-Blebbistatin enables precise, reversible inhibition of non-muscle myosin II, empowering researchers to dissect actin-myosin mechanics in cell adhesion, migration, and mechanotransduction studies. This guide delivers advanced protocols, troubleshooting insights, and real-world applications—grounded in recent breakthroughs and comparative evidence.

• CHI3L1-IN-5: Applied Neuroinflammation Blockade in Alzheimer

  2026-05-16

  CHI3L1-IN-5 (Compound Z17) uniquely enables researchers to block CHI3L1-mediated inflammatory pathways and restore astrocytic amyloid-beta clearance in neurodegeneration models. This article delivers stepwise protocols, troubleshooting guidance, and comparative insights, grounded in recent high-impact research and tailored for translational neuroscience.

764 records 17/51 page Previous Next First page 上5页 1617181920 下5页 Last page